The Long-Term Omalizumab Therapy in Children with Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry

Background: Patient registries help to obtain relevant information about the peculiarities of certain diseases, as well as the safety and effectiveness of different medical technologies. Moreover, it allows conducting a continuous monitoring in a studied group. Objective: to analyze the effectivenes...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Elena A. Vishneva, Leyla S. Namazova-Baranova, Elena A. Dobrynina, Anna A. Alekseeva, Vladimir I. Smirnov, Julia G. Levina, Vera G. Kalugina, Kamilla E. Efendieva, Konstantin S. Volkov
Formato:	Artigo
Idioma:	Russo
Publicado em:	Union of pediatricians of Russia 2018-05-01
coleção:	Педиатрическая фармакология
Assuntos:	registry severe asthma recombinant monoclonal antibody omalizumab long-term therapy effectiveness safety children
Acesso em linha:	https://www.pedpharma.ru/jour/article/view/1617
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!